These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synthesis and anti-hepatocellular carcinoma activity of novel O Zou Y; Yan C; Liu JC; Huang ZJ; Xu JY; Zhou JP; Zhang HB; Zhang YH Chin J Nat Med; 2017 Dec; 15(12):928-937. PubMed ID: 29329650 [TBL] [Abstract][Full Text] [Related]
4. Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability. Fu J; Liu L; Huang Z; Lai Y; Ji H; Peng S; Tian J; Zhang Y J Med Chem; 2013 Jun; 56(11):4641-55. PubMed ID: 23617697 [TBL] [Abstract][Full Text] [Related]
5. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity. Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents. Lai Y; Shen L; Zhang Z; Liu W; Zhang Y; Ji H; Tian J Bioorg Med Chem Lett; 2010 Nov; 20(22):6416-20. PubMed ID: 20932754 [TBL] [Abstract][Full Text] [Related]
7. YAP and 14-3-3γ are involved in HS-OA-induced growth inhibition of hepatocellular carcinoma cells: A novel mechanism for hydrogen sulfide releasing oleanolic acid. Xu G; Wang J; Wu F; Wang N; Zhou W; Wang Q; Pan W; Ao G; Yang J Oncotarget; 2016 Aug; 7(32):52150-52165. PubMed ID: 27437776 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis. Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993 [TBL] [Abstract][Full Text] [Related]
9. Glycosylated diazeniumdiolate-based oleanolic acid derivatives: synthesis, in vitro and in vivo biological evaluation as anti-human hepatocellular carcinoma agents. Huang Z; Fu J; Liu L; Sun Y; Lai Y; Ji H; Knaus EE; Tian J; Zhang Y Org Biomol Chem; 2012 May; 10(19):3882-91. PubMed ID: 22473516 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, Characterization and Anti-hepatoma Activity of New Hederagenin Derivatives. Liu X; Sun L; Liu QH; Chen BQ; Liu YM Mini Rev Med Chem; 2020; 20(3):252-257. PubMed ID: 32134368 [TBL] [Abstract][Full Text] [Related]
11. A library of 1,2,3-triazole-substituted oleanolic acid derivatives as anticancer agents: design, synthesis, and biological evaluation. Wei G; Luan W; Wang S; Cui S; Li F; Liu Y; Liu Y; Cheng M Org Biomol Chem; 2015 Feb; 13(5):1507-14. PubMed ID: 25476168 [TBL] [Abstract][Full Text] [Related]
12. Identification of a novel oxidative stress induced cell death by Sorafenib and oleanolic acid in human hepatocellular carcinoma cells. Lange M; Abhari BA; Hinrichs TM; Fulda S; Liese J Biochem Pharmacol; 2016 Oct; 118():9-17. PubMed ID: 27544320 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties. Wang R; Yang W; Fan Y; Dehaen W; Li Y; Li H; Wang W; Zheng Q; Huai Q Bioorg Chem; 2019 Jul; 88():102951. PubMed ID: 31054427 [TBL] [Abstract][Full Text] [Related]
14. Interaction characteristics with bovine serum albumin and retarded nitric oxide release of ZCVI₄-2, a new nitric oxide-releasing derivative of oleanolic acid. Zhang J; Gao Y; Su F; Gong Z; Zhang Y Chem Pharm Bull (Tokyo); 2011; 59(6):734-41. PubMed ID: 21628910 [TBL] [Abstract][Full Text] [Related]
15. [Synthesis and biological evaluation of nitrate-oleanolic acid hybrids as inhibitors of HepG2 cell apoptosis]. Chen L; Shang J; Wang ZF; Zhang YH; Tian JD Yao Xue Xue Bao; 2010 Dec; 45(12):1516-22. PubMed ID: 21351491 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives. Hao J; Liu J; Wen X; Sun H Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227 [TBL] [Abstract][Full Text] [Related]
17. Cotreatment with sorafenib and oleanolic acid induces reactive oxygen species-dependent and mitochondrial-mediated apoptotic cell death in hepatocellular carcinoma cells. Liese J; Hinrichs TM; Lange M; Fulda S Anticancer Drugs; 2019 Mar; 30(3):209-217. PubMed ID: 30640794 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and antitumor activity of oleanolic acid derivatives. Meng YQ; Kuai ZY; Zhan SW; Li CL; Chen HR J Asian Nat Prod Res; 2019 Jul; 21(7):633-651. PubMed ID: 29733221 [TBL] [Abstract][Full Text] [Related]
19. Oleanolic acid-NO donor-platinum(II) trihybrid molecules: Targeting cytotoxicity on hepatoma cells with combined action mode and good safety. Fang L; Feng M; Chen F; Liu X; Shen H; Zhao J; Gou S Bioorg Med Chem; 2016 Oct; 24(19):4611-4619. PubMed ID: 27501909 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel oleanolic acid and ursolic acid in C-28 position derivatives as potential anticancer agents. Tian T; Liu X; Lee ES; Sun J; Feng Z; Zhao L; Zhao C Arch Pharm Res; 2017 Apr; 40(4):458-468. PubMed ID: 28101738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]